Evaluate Pharmacists’ Mental Health Amid COVID-19
Pharmacists should engage in a continuous self-assessment of their mental health status and identify any signs of anxiety, depression, or stress.
Rural Pharmacies Respond to COVID-19 Pandemic with Change in Outreach Services
Patients in rural areas continue to face challenges to care, such as poverty, inconsistent information about the virus, and lack of transportation.
Pharmacists working collaboratively can make an impact, including for patients with more acute diseases.
The Department of Health and Human Services said that there are only 5 locations out of 67,000 pharmacy sites with the capacity to test for COVID-19 through the Community-Based Testing Site program.
Today’s pharmacy hero is Shawn Hodges, PharmD, of Innovation Compounding Pharmacy in Kennesaw, Georgia.
Rural community pharmacies evolve to continue serving low-income patients with chronic conditions during the coronavirus disease 2019 pandemic.
The announcement is in response to ongoing reports of contamination with N-Nitrosodimethylamine (NDMA).
The collaboration will combine VBI’s viral vaccine experience and coronavirus antigens with the NRC’s unique COVID-19 antigens and assay development capabilities.
The FDA has announced that it is accelerating the development of potentially safe and effective life-saving treatments for patients with the coronavirus 2019 disease.
New advances in medical therapy have made it possible for rosacea patients to achieve clear skin.
Key best practices for protecting pharmacy personnel during the COVID-19 pandemic.
The prevalence of HIV in jails and prisons is approximately 4 times higher than that of the general United States population.
Study: Liquid Biopsies a Possible Method for Improved Breast Cancer Detection, Monitoring Progression
Genomic profiles measured through circulating free DNA in the blood of patients with breast cancer may provide a more effective way to treat the disease and track its progression.
Study: Rivaroxaban Reduces Risk of Major Venous Thromboembolism Following Nonmajor Orthopedic Surgery
Study shows rivaroxaban (Xarelto, Bayer) following nonmajor orthopedic surgery reduced the risk of major venous thromboembolism by approximately 75% compared with enoxaparin.